-
Mid-Size Pharmaceuticals Market Analysis 2025 – Insights For Long-Term Investment & Planning
30 Jun 2025 10:28 GMT
The Business Research Company's Mid-Size Pharmaceuticals Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, June 30, 2025 /EINPresswire.com/ -- How Big Is The Global Mid- …
-
Medical Fluid Bag Market Worth $6,057.60 million by 2030 With CAGR of 5.50% | Fresenius Kabi, Hospira, Pall Corporation
02 Sep 2024 13:08 GMT
… , top segments, value chain, key investment pockets, regional scenario, and competitive … , Baxter International, ConvaTec, Fresenius Kabi, Hospira Inc., Pall Corporation, Smiths Medical …
-
Lyme Disease Treatment Market to Witness Astonishing Growth by 2031: Sandoz AG, GlaxoSmithKline plc., and Hospira Inc.
19 Feb 2024 09:40 GMT
… development and boost return on investment (ROI). The region that is … Ltd.
◘ Sandoz AG
◘ GlaxoSmithKline plc.
◘ Hospira Inc.
Lyme Disease Treatment Market …
-
Andhra, Telangana luring more pharma investments
21 Aug 2023 09:06 GMT
… as to attract new investments in manufacturing and allied … are luring considerable pharma investments.
While Andhra Pradesh has … has been recognized as National Investment and Manufacturing Zone (NIMZ … number of pharma companies like Hospira, Mylan, Reddy’s Lab …
-
Generic Drugs Market USD 551330 million by 2028 | Top Regions, Development, Key Players, Market Dynamics | Sales, Price, Revenue, Gross Margin, Cost Analysis| Future Investment, Expansion Plan
04 Nov 2022 12:49 GMT
Pune, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Generic Drugs market report shares valuable information about global development status, opportunities, and challenges in near future, as past data analyzed by industry experts which is helpful for you to take …
-
Pain Management Therapeutics Market Industry Landscape & Acknowledgment 2028 | Averitas Pharma, Cardinal Health, Hospira
21 Sep 2022 10:48 GMT
… Mapping of Market Parameters
• Attractive Investment Proposition in the Global Market … ., Forest Laboratories, Inc., GlaxoSmithKline plc, Hospira, Inc., Merck & Co., Inc …
-
Worldwide Epinephrine Autoinjector Industry to 2028 - Featuring Pfizer, Mylan, Sanofi and Hospira Among Others - ResearchAndMarkets.com
19 Sep 2022 15:42 GMT
… brings an insight into the investment areas that existing or new … Pharmaceuticals Ltd
Antares Pharma Inc.
Hospira Inc.
Impax Laboratories, Inc.
Bausch …
-
$880 Million Worldwide Filgrastim Biosimilars Industry to 2031 - Identify Growth Segments for Investment - ResearchAndMarkets.com
22 Apr 2022 10:00 GMT
…
Claris Life Sciences
Adello Biologics
Hospira (Pfizer)
Gennova Biopharmaceuticals
Teva Pharmaceuticals … analysis
Identify growth segments for investment
Outperform competitors using forecast data …
-
Global Infusion Pumps Market to 2029 - Featuring Baxter International, Medtronic and Hospira Among Others - ResearchAndMarkets.com
28 Mar 2022 09:57 GMT
… & Johnson Corporation
Medtronic Plc.
Hospira
Terumo Corporation
Smiths Medical
This … analysis tools such as attractive investment proposition and fractal map analysis … Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis …
-
Global Oncology Biosimilars Market (2022 to 2031) - Featuring Pfizer, Amgen and Hospira Among Others - ResearchAndMarkets.com
21 Mar 2022 15:31 GMT
… .
Sandoz International GmbH
BIOCAD
Amgen
Hospira
F.Hoffmann-La Roche
Baxter … analysis
Identify growth segments for investment
Outperform competitors using forecast data …
About
© 1995-2025